Correction: In vitro drug testing using patient-derived ovarian cancer organoids.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Works by Chu, Ling-Hui
Results: 7
1
2
In vitro drug testing using patient-derived ovarian cancer organoids.
- Published in:
- Journal of Ovarian Research, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13048-024-01520-2
- By:
- Publication type:
- Article
3
The mediating role of self-regulation on harmonious passion, obsessive passion, and knowledge management in e-learning.
- Published in:
- Educational Technology Research & Development, 2018, v. 66, n. 3, p. 615, doi. 10.1007/s11423-017-9562-x
- By:
- Publication type:
- Article
4
Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4343, doi. 10.3390/cancers14174343
- By:
- Publication type:
- Article
5
Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 5973, doi. 10.3390/ijms23115973
- By:
- Publication type:
- Article
6
Epigenomic Profiling of Epithelial Ovarian Cancer Stem-Cell Differentiation Reveals GPD1 Associated Immune Suppressive Microenvironment and Poor Prognosis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 5120, doi. 10.3390/ijms23095120
- By:
- Publication type:
- Article
7
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor.
- Published in:
- Antioxidants, 2024, v. 13, n. 6, p. 735, doi. 10.3390/antiox13060735
- By:
- Publication type:
- Article